Kestra Medical Technologies, Ltd. reports results for the quarter ended April 30 - Earnings Summary

Kestra Medical Technologies

14/09/2026 22:01

Kestra Medical Technologies, Ltd. KMTS.OQ reported a quarterly adjusted loss of 65 cents​​ per share for the quarter ended April 30, higher than the same quarter last year, when the company reported EPS of $-2.21.  The mean expectation of seven analysts for the quarter was for a loss of 60 cents per share. Wall Street expected results to range from -63 cents to -54 cents per share.
Revenue rose 47.8% to $28.64 million from a year ago; analysts expected $26.48 million. 
Kestra Medical Technologies, Ltd.'s reported EPS for the quarter was a loss of 67 cents​.
The company reported a quarterly loss of $44.09 million.
Kestra Medical Technologies, Ltd. shares had fallen by 10.2% this quarter and lost 13.8% so far this year.
FORECAST CHANGES
The mean earnings estimate of analysts was unchanged in the last three months.​ 
In the last 30 days, there have been no negative revisions of earnings estimates
RECOMMENDATIONS
The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 7 "strong buy" or "buy," 1 "hold" and no "sell" or "strong sell." The average consensus recommendation for the advanced medical equipment & technology peer group is also "buy" 
Wall Street's median 12-month price target for Kestra Medical Technologies, Ltd. is $30.00, about 23.8% above its last closing price of $22.85
This summary was machine generated from LSEG data September 14 at 09:01 p.m. UTC. ​All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)
QUARTER ENDING
ESTIMATE 
ACTUAL
BEAT, MET, MISSED
Jul. 31 2026 
-0.62
-0.65
Missed
Apr. 30 2026 
-0.60
-0.61
Missed
Oct. 31 2025 
-0.60
-0.64
Missed
Jul. 31 2025 
-0.76
-0.45
Beat